William Blair Reduces Earnings Estimates for Addus HomeCare

Key Points

• William Blair has reduced its earnings estimates for Addus HomeCare's Q3 2025 EPS from $1.41 to $1.36, while the full-year earnings estimate remains at $4.59 per share.
• Despite the decreased EPS estimates, Addus HomeCare has received multiple upgrades from analysts, including a "buy" rating from Wall Street Zen and an increased target price from TD Cowen to $139.00.
• The company reported a revenue increase of 21.8% year-over-year for the latest quarter, achieving $349.44 million against expectations of $345.71 million, with an EPS of $1.49.

Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) - Stock analysts at William Blair cut their Q3 2025 earnings per share estimates for Addus HomeCare in a research report issued to clients and investors on Wednesday, August 6th. William Blair analyst J. Haase now anticipates that the company will post earnings per share of $1.36 for the quarter, down from their previous estimate of $1.41. The consensus estimate for Addus HomeCare's current full-year earnings is $4.59 per share. William Blair also issued estimates for Addus HomeCare's Q4 2025 earnings at $1.49 EPS, FY2025 earnings at $5.44 EPS and FY2026 earnings at $6.06 EPS.

Several other equities analysts have also recently weighed in on ADUS. Macquarie restated an "outperform" rating and set a $133.00 price target on shares of Addus HomeCare in a report on Tuesday, June 10th. Wall Street Zen raised Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday, June 29th. JMP Securities reissued a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Wednesday, July 16th. Finally, TD Cowen boosted their target price on Addus HomeCare from $135.00 to $139.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Seven research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Addus HomeCare presently has an average rating of "Buy" and a consensus target price of $142.86.

Addus HomeCare Price Performance

NASDAQ ADUS traded up $3.41 during trading on Monday, hitting $116.47. 187,720 shares of the stock traded hands, compared to its average volume of 193,700. The company has a market capitalization of $2.14 billion, a P/E ratio of 25.81, a price-to-earnings-growth ratio of 1.71 and a beta of 0.80. The firm has a 50-day simple moving average of $111.75 and a 200-day simple moving average of $107.63. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. Addus HomeCare has a 12-month low of $88.96 and a 12-month high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.45 by $0.04. The business had revenue of $349.44 million during the quarter, compared to analysts' expectations of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%. The firm's revenue for the quarter was up 21.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.35 EPS.

Hedge Funds Weigh In On Addus HomeCare

Large investors have recently bought and sold shares of the business. Natixis lifted its holdings in shares of Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after buying an additional 132 shares during the period. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of Addus HomeCare in the 1st quarter worth $41,000. CWM LLC lifted its holdings in shares of Addus HomeCare by 25.3% in the 2nd quarter. CWM LLC now owns 554 shares of the company's stock worth $64,000 after buying an additional 112 shares during the period. Parkside Financial Bank & Trust lifted its holdings in shares of Addus HomeCare by 22.9% in the 2nd quarter. Parkside Financial Bank & Trust now owns 661 shares of the company's stock worth $76,000 after buying an additional 123 shares during the period. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in shares of Addus HomeCare by 368.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company's stock worth $124,000 after buying an additional 987 shares during the period. Hedge funds and other institutional investors own 95.35% of the company's stock.

Insider Transactions at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the transaction, the executive vice president owned 7,796 shares in the company, valued at $896,540. The trade was a 20.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.50% of the stock is currently owned by insiders.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.